CN108611326B - 一种高效的慢病毒生产体系及其生产方法 - Google Patents
一种高效的慢病毒生产体系及其生产方法 Download PDFInfo
- Publication number
- CN108611326B CN108611326B CN201810371657.7A CN201810371657A CN108611326B CN 108611326 B CN108611326 B CN 108611326B CN 201810371657 A CN201810371657 A CN 201810371657A CN 108611326 B CN108611326 B CN 108611326B
- Authority
- CN
- China
- Prior art keywords
- plasmid
- vsvg
- gene
- vector plasmid
- plp2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
质粒总量(μg) | 比例 | 病毒滴度 |
120μg | 20:13:5:20 | 1.59E+06 |
100μg | 20:13:5:20 | 1.52E+06 |
80μg | 20:13:5:20 | 1.67E+06 |
60μg | 20:13:5:20 | 2.14E+06 |
40μg | 20:13:5:20 | 2.59E+06 |
20μg | 20:13:5:20 | NA |
33μg | 20:13:5:20 | 1.74E+06 |
33μg | 9:6:9:8 | 4.67E+06 |
质粒总量(μg) | 比例 | 病毒滴度 |
60 | 20:13:5:20 | 8.86E+06 |
60 | 9:6:9:8 | 7.11E+06 |
40 | 20:13:5:20 | 2.07E+07 |
40 | 9:6:9:8 | 2.24E+07 |
33 | 9:6:9:8 | 3.59E+07 |
20 | 9:6:9:8 | 3.63E+07 |
质粒总量(μg) | 比例 | 病毒滴度 |
33 | 9:6:9:8 | 6.67E+06 |
33 | 9:6:9:12 | 5.97E+06 |
33 | 12:6:3:7 | 2.97E+06 |
33 | 8:4:2:7 | 4.62E+06 |
33 | 10.5:27:10.5:9.5 | 4.34E+06 |
33 | 0.9:0.3:0.5:1.3 | 5.10E+06 |
33 | 9:9:6:8 | 6.08E+06 |
33 | 9:9:6:12 | 5.78E+06 |
33 | 6:9:9:8 | 4.51E+06 |
33 | 6:9:9:12 | 4.90E+06 |
33 | 1:1:1:1 | 5.84E+06 |
33 | 2:2:2:3 | 6.62E+06 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810371657.7A CN108611326B (zh) | 2018-04-24 | 2018-04-24 | 一种高效的慢病毒生产体系及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810371657.7A CN108611326B (zh) | 2018-04-24 | 2018-04-24 | 一种高效的慢病毒生产体系及其生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108611326A CN108611326A (zh) | 2018-10-02 |
CN108611326B true CN108611326B (zh) | 2019-07-19 |
Family
ID=63660677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810371657.7A Active CN108611326B (zh) | 2018-04-24 | 2018-04-24 | 一种高效的慢病毒生产体系及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108611326B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113584083A (zh) * | 2020-04-30 | 2021-11-02 | 深圳市深研生物科技有限公司 | 用于逆转录病毒载体的生产细胞和包装细胞及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004024905A1 (fr) * | 2002-09-10 | 2004-03-25 | Agtc Gene Technology Company Ltd. | Virus de l'herpes simplex humain recombine pour la production de vecteurs lentivirus |
CN102140442A (zh) * | 2010-02-01 | 2011-08-03 | 北京大学深圳医院 | 重组慢病毒及其制备方法和应用 |
-
2018
- 2018-04-24 CN CN201810371657.7A patent/CN108611326B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004024905A1 (fr) * | 2002-09-10 | 2004-03-25 | Agtc Gene Technology Company Ltd. | Virus de l'herpes simplex humain recombine pour la production de vecteurs lentivirus |
CN102140442A (zh) * | 2010-02-01 | 2011-08-03 | 北京大学深圳医院 | 重组慢病毒及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
Development and Optimization of a High Titer Recombinant Lentivirus System;Storck, A等;《BIOTECHNIQUES》;20170930;第63卷(第3期);第136-138页 |
第三代慢病毒包装系统优化及Rev表达质粒对慢病毒包装效率作用初探;阮峥等;《生物技术通讯》;20141103;第25卷(第6期);第770-773页 |
Also Published As
Publication number | Publication date |
---|---|
CN108611326A (zh) | 2018-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Naldini et al. | In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | |
Olsen | Gene transfer vectors derived from equine infectious anemia virus | |
Kawai et al. | New procedure for DNA transfection with polycation and dimethyl sulfoxide | |
Felber et al. | A quantitative bioassay for HIV-1 based on trans-activation | |
US7226780B2 (en) | Lentivirus vector system | |
Trobridge et al. | Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors | |
RU2729385C2 (ru) | Биопроизводство лентивирусных векторов | |
US11845962B2 (en) | Method for large-scale production of lentivirus by using GMP-level serum-free suspension cells | |
CN102260667A (zh) | 细胞微粒子-siRNA复合物的制备及其在艾滋病治疗中的应用 | |
CN103842500A (zh) | 可用于转导真核细胞的基于病毒的载体组合物 | |
Chen et al. | Cytoplasmic tail truncation of SARS-CoV-2 spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation | |
CN107384872B (zh) | 高滴度慢病毒的制备试剂盒及其应用 | |
CN108611326B (zh) | 一种高效的慢病毒生产体系及其生产方法 | |
CN101353666B (zh) | 一种hiv药物筛选细胞模型及其专用假型慢病毒 | |
WO2000040741A2 (en) | Lentivirus vector system | |
Borok et al. | Vesicular stomatitis virus G-pseudotyped lentivirus vectors mediate efficient apical transduction of polarized quiescent primary alveolar epithelial cells | |
Toscano et al. | Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies | |
EP2578236B1 (en) | PREPARATION OF MICROVESICLE-siRNA COMPLEXES AND USE THEREOF IN AIDS TREATMENT | |
CN105039411A (zh) | 附着型慢病毒载体、制备方法及应用 | |
WO2023072178A1 (en) | Methods for developing a cell line for producing virus in suspension cell culture | |
Leath et al. | Developing novel lentiviral vectors into clinical products | |
Stevenson et al. | Molecular basis of cell cycle dependent HIV-1 replication: implications for control of virus burden | |
Gu et al. | The enhancement of RNAi against HIV in vitro and in vivo using H-2Kk protein as a sorting method | |
Zufferey et al. | Production of high‐titer lentiviral vectors | |
Kasper et al. | Efficient manipulation of Hedgehog/GLI signaling using retroviral expression systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200831 Address after: No.1 Workshop, No.45, Dongjiu Road, Tianjin pilot free trade zone (Airport Economic Zone), Jinghai District, Tianjin Patentee after: Yingwei fosai Biotechnology (Tianjin) Co.,Ltd. Address before: 100032 No. 9, North Third Ring Road, Xicheng District, Beijing Patentee before: Gao Shan |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220531 Address after: 100176 306a, floor 3, building 4, Yongchang Middle Road, Beijing Economic and Technological Development Zone, Daxing District, Beijing Patentee after: Beijing Zhongke Weiyuan Biotechnology Co.,Ltd. Address before: 300000 plant 1, No. 45, East 9th Road, Tianjin pilot free trade zone (Airport Economic Zone), Jinghai District, Tianjin Patentee before: Yingwei fosai Biotechnology (Tianjin) Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 306A, 3rd Floor, Building 4, Yard 4, Yongchang Middle Road, Economic and Technological Development Zone, Daxing District, Beijing 100176 Patentee after: Yingkaisaiwei (Beijing) Biotechnology Co.,Ltd. Address before: 100176 306a, floor 3, building 4, Yongchang Middle Road, Beijing Economic and Technological Development Zone, Daxing District, Beijing Patentee before: Beijing Zhongke Weiyuan Biotechnology Co.,Ltd. |